A promising treatment to extend the lives of glioblastoma patients is waiting on the worst form of bureaucracy ...

Wearable Device to Treat Brain Cancer by Using Electrical Stimulation Medically reviewed by Brigid Dwyer, MD Optune is a ...

Then my radiation oncologist asked if I’d be interested in trying a medical device called Optune® for the treatment of glioblastoma multiforme (GBM) and walked me through the risks and benefits.

A head patch device that delivers alternating ... improve survival in newly diagnosed glioblastoma patients. Developed by Jersey, US-based Novocure, Optune beams so-called Tumour Treating ...

Finding a drug to advance treatment of glioblastoma (GBM) is one of the hardest challenges in pharma, and adding the Optune medical device to a phase 1b study of its investigational drug marizomib ...

Novocure’s device, Optune, was approved by the US Food and Drug Administration (FDA) in 2011 to treat recurrent glioblastoma multiforme (GBM), and in 2015 to treat newly diagnosed GBM in ...

With standard care, just five per cent of glioblastoma patients will still be alive five years after diagnosis; when TTFields were combined with this approach, it was 13 per cent. However, for the ...

The Optune device is a wearable, portable instrument that uses external electrodes attached ... groundwork and developing the technology for a new treatment modality in the fight against ...